HEADER HYDROLASE/INHIBITOR 28-JUN-23 8TBK TITLE TRICOMPLEX OF RMC-7977, KRAS G12C, AND CYPA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GTPASE KRAS; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: K-RAS 2,KI-RAS,C-K-RAS,C-KI-RAS; COMPND 5 EC: 3.6.5.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: PPIASE A,CYCLOPHILIN A,CYCLOSPORIN A-BINDING PROTEIN, COMPND 12 ROTAMASE A; COMPND 13 EC: 5.2.1.8; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KRAS, KRAS2, RASK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PPIA, CYPA; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, SMALL GTPASE, CANCER, TRICOMPLEX, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.C.A.TOMLINSON,A.CHEN,J.E.KNOX,J.K.YANO REVDAT 2 24-APR-24 8TBK 1 JRNL REVDAT 1 07-FEB-24 8TBK 0 JRNL AUTH M.HOLDERFIELD,B.J.LEE,J.JIANG,A.TOMLINSON,K.J.SEAMON,A.MIRA, JRNL AUTH 2 E.PATRUCCO,G.GOODHART,J.DILLY,Y.GINDIN,N.DINGLASAN,Y.WANG, JRNL AUTH 3 L.P.LAI,S.CAI,L.JIANG,N.NASHOLM,N.SHIFRIN,C.BLAJ,H.SHAH, JRNL AUTH 4 J.W.EVANS,N.MONTAZER,O.LAI,J.SHI,E.AHLER,E.QUINTANA,S.CHANG, JRNL AUTH 5 A.SALVADOR,A.MARQUEZ,J.CREGG,Y.LIU,A.MILIN,A.CHEN,T.B.ZIV, JRNL AUTH 6 D.PARSONS,J.E.KNOX,J.E.KLOMP,J.ROTH,M.REES,M.RONAN, JRNL AUTH 7 A.CUEVAS-NAVARRO,F.HU,P.LITO,D.SANTAMARIA,A.J.AGUIRRE, JRNL AUTH 8 A.M.WATERS,C.J.DER,C.AMBROGIO,Z.WANG,A.L.GILL,E.S.KOLTUN, JRNL AUTH 9 J.A.M.SMITH,D.WILDES,M.SINGH JRNL TITL CONCURRENT INHIBITION OF ONCOGENIC AND WILD-TYPE RAS-GTP FOR JRNL TITL 2 CANCER THERAPY. JRNL REF NATURE 2024 JRNL REFN ESSN 1476-4687 JRNL PMID 38589574 JRNL DOI 10.1038/S41586-024-07205-6 REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 183456 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.148 REMARK 3 R VALUE (WORKING SET) : 0.146 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 9267 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.9200 - 3.9100 1.00 6263 333 0.1382 0.1665 REMARK 3 2 3.9100 - 3.1100 1.00 6032 319 0.1327 0.1715 REMARK 3 3 3.1100 - 2.7100 1.00 5999 321 0.1486 0.1863 REMARK 3 4 2.7100 - 2.4700 1.00 5975 299 0.1495 0.1747 REMARK 3 5 2.4700 - 2.2900 1.00 5945 337 0.1399 0.1783 REMARK 3 6 2.2900 - 2.1500 1.00 5956 281 0.1384 0.1732 REMARK 3 7 2.1500 - 2.0500 1.00 5916 283 0.1351 0.1791 REMARK 3 8 2.0500 - 1.9600 0.99 5881 335 0.1279 0.1684 REMARK 3 9 1.9600 - 1.8800 0.99 5884 313 0.1237 0.1659 REMARK 3 10 1.8800 - 1.8200 0.99 5842 302 0.1272 0.1704 REMARK 3 11 1.8200 - 1.7600 0.99 5845 288 0.1343 0.1729 REMARK 3 12 1.7600 - 1.7100 0.99 5782 351 0.1378 0.1903 REMARK 3 13 1.7100 - 1.6700 0.99 5814 311 0.1340 0.1765 REMARK 3 14 1.6700 - 1.6200 0.99 5807 323 0.1263 0.1774 REMARK 3 15 1.6200 - 1.5900 0.99 5733 350 0.1292 0.1716 REMARK 3 16 1.5900 - 1.5500 0.98 5783 303 0.1382 0.1878 REMARK 3 17 1.5500 - 1.5200 0.98 5775 323 0.1411 0.1877 REMARK 3 18 1.5200 - 1.4900 0.98 5725 316 0.1515 0.1826 REMARK 3 19 1.4900 - 1.4700 0.98 5731 318 0.1581 0.2141 REMARK 3 20 1.4700 - 1.4400 0.98 5780 292 0.1727 0.2173 REMARK 3 21 1.4400 - 1.4200 0.98 5722 302 0.1874 0.2416 REMARK 3 22 1.4200 - 1.4000 0.97 5722 286 0.2001 0.2460 REMARK 3 23 1.4000 - 1.3800 0.97 5755 281 0.2125 0.2661 REMARK 3 24 1.3800 - 1.3600 0.97 5708 313 0.2279 0.2688 REMARK 3 25 1.3600 - 1.3400 0.97 5643 337 0.2308 0.2793 REMARK 3 26 1.3400 - 1.3200 0.97 5700 291 0.2475 0.2832 REMARK 3 27 1.3200 - 1.3100 0.97 5654 281 0.2599 0.3018 REMARK 3 28 1.3100 - 1.2900 0.97 5704 294 0.2690 0.3049 REMARK 3 29 1.2900 - 1.2700 0.96 5593 295 0.2857 0.3011 REMARK 3 30 1.2700 - 1.2600 0.95 5520 289 0.3054 0.3457 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.145 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.755 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 5658 REMARK 3 ANGLE : 0.868 7667 REMARK 3 CHIRALITY : 0.080 814 REMARK 3 PLANARITY : 0.005 996 REMARK 3 DIHEDRAL : 14.417 2176 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TBK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000275598. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95375 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 183467 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.260 REMARK 200 RESOLUTION RANGE LOW (A) : 39.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.07469 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 1.94900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% PEG4000, 0.1 M IMIDAZOLE, PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.73500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.10500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.78500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.10500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.73500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.78500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 SER D 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 36 -68.09 -90.10 REMARK 500 LYS A 117 32.13 74.84 REMARK 500 SER A 122 45.30 -96.88 REMARK 500 ASP B 108 72.80 -119.34 REMARK 500 LYS B 117 32.94 70.82 REMARK 500 SER B 122 45.78 -84.80 REMARK 500 PHE C 60 -66.82 -131.18 REMARK 500 PHE C 60 -66.89 -131.18 REMARK 500 PHE D 60 -69.55 -131.93 REMARK 500 PHE D 60 -69.26 -131.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 578 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH C 579 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH C 580 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH C 581 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH C 582 DISTANCE = 7.03 ANGSTROMS REMARK 525 HOH D 562 DISTANCE = 6.01 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 17 OG REMARK 620 2 THR A 35 OG1 82.9 REMARK 620 3 GNP A 201 O1G 173.5 90.7 REMARK 620 4 GNP A 201 O2B 91.8 174.6 94.7 REMARK 620 5 HOH A 324 O 86.8 91.8 92.5 88.7 REMARK 620 6 HOH A 336 O 89.0 90.1 91.9 89.0 175.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 17 OG REMARK 620 2 THR B 35 OG1 82.5 REMARK 620 3 GNP B 201 O1G 172.7 90.3 REMARK 620 4 GNP B 201 O2B 92.6 175.0 94.7 REMARK 620 5 HOH B 327 O 85.7 89.8 93.2 90.6 REMARK 620 6 HOH B 359 O 88.5 90.6 92.7 88.5 174.1 REMARK 620 N 1 2 3 4 5 DBREF 8TBK A 1 169 UNP P01116 RASK_HUMAN 1 169 DBREF 8TBK B 1 169 UNP P01116 RASK_HUMAN 1 169 DBREF 8TBK C 1 165 UNP P62937 PPIA_HUMAN 1 165 DBREF 8TBK D 1 165 UNP P62937 PPIA_HUMAN 1 165 SEQADV 8TBK SER A 0 UNP P01116 EXPRESSION TAG SEQADV 8TBK CYS A 12 UNP P01116 GLY 12 ENGINEERED MUTATION SEQADV 8TBK SER B 0 UNP P01116 EXPRESSION TAG SEQADV 8TBK CYS B 12 UNP P01116 GLY 12 ENGINEERED MUTATION SEQADV 8TBK SER C 0 UNP P62937 EXPRESSION TAG SEQADV 8TBK SER D 0 UNP P62937 EXPRESSION TAG SEQRES 1 A 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA CYS SEQRES 2 A 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 A 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 A 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS SEQRES 5 A 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 A 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 A 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 A 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 A 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 A 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 A 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 A 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 A 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 A 170 LYS SEQRES 1 B 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA CYS SEQRES 2 B 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 B 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 B 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS SEQRES 5 B 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 B 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 B 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 B 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 B 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 B 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 B 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 B 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 B 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 B 170 LYS SEQRES 1 C 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL SEQRES 2 C 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE SEQRES 3 C 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA SEQRES 4 C 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER SEQRES 5 C 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY SEQRES 6 C 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER SEQRES 7 C 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU SEQRES 8 C 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA SEQRES 9 C 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR SEQRES 10 C 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE SEQRES 11 C 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET SEQRES 12 C 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS SEQRES 13 C 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 D 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL SEQRES 2 D 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE SEQRES 3 D 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA SEQRES 4 D 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER SEQRES 5 D 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY SEQRES 6 D 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER SEQRES 7 D 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU SEQRES 8 D 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA SEQRES 9 D 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR SEQRES 10 D 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE SEQRES 11 D 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET SEQRES 12 D 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS SEQRES 13 D 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU HET GNP A 201 32 HET MG A 202 1 HET GNP B 201 32 HET MG B 202 1 HET ZNI C 201 62 HET ZNI D 201 62 HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION HETNAM ZNI (1R,5S,6R)-N-[(1P,7S,9S,13S,20M)-20-{5-(4- HETNAM 2 ZNI CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1- HETNAM 3 ZNI METHOXYETHYL]PYRIDIN-3-YL}-21-ETHYL-17,17-DIMETHYL-8, HETNAM 4 ZNI 14-DIOXO-15-OXA-4-THIA-9,21,27,28- HETNAM 5 ZNI TETRAAZAPENTACYCLO[17.5.2.1~2,5~.1~9,13~.0~22, HETNAM 6 ZNI 26~]OCTACOSA-1(24),2,5(28),19,22,25-HEXAEN-7-YL]-3- HETNAM 7 ZNI OXABICYCLO[3.1.0]HEXANE-6-CARBOXAMIDE HETSYN ZNI RMC-7977 FORMUL 5 GNP 2(C10 H17 N6 O13 P3) FORMUL 6 MG 2(MG 2+) FORMUL 9 ZNI 2(C47 H60 N8 O6 S) FORMUL 11 HOH *984(H2 O) HELIX 1 AA1 GLY A 15 ASN A 26 1 12 HELIX 2 AA2 GLN A 61 MET A 67 5 7 HELIX 3 AA3 ARG A 68 GLY A 75 1 8 HELIX 4 AA4 ASN A 86 ASP A 105 1 20 HELIX 5 AA5 ASP A 126 GLY A 138 1 13 HELIX 6 AA6 GLY A 151 LYS A 169 1 19 HELIX 7 AA7 GLY B 15 ASN B 26 1 12 HELIX 8 AA8 GLN B 61 MET B 67 5 7 HELIX 9 AA9 ARG B 68 GLY B 75 1 8 HELIX 10 AB1 ASN B 86 ASP B 105 1 20 HELIX 11 AB2 ASP B 126 GLY B 138 1 13 HELIX 12 AB3 GLY B 151 GLU B 168 1 18 HELIX 13 AB4 VAL C 29 GLY C 42 1 14 HELIX 14 AB5 THR C 119 ASP C 123 5 5 HELIX 15 AB6 GLY C 135 GLU C 143 1 9 HELIX 16 AB7 ARG C 144 GLY C 146 5 3 HELIX 17 AB8 VAL D 29 GLY D 42 1 14 HELIX 18 AB9 THR D 119 ASP D 123 5 5 HELIX 19 AC1 GLY D 135 GLU D 143 1 9 HELIX 20 AC2 ARG D 144 GLY D 146 5 3 SHEET 1 AA1 6 GLU A 37 ILE A 46 0 SHEET 2 AA1 6 GLU A 49 THR A 58 -1 O LEU A 53 N LYS A 42 SHEET 3 AA1 6 THR A 2 VAL A 9 1 N TYR A 4 O ASP A 54 SHEET 4 AA1 6 GLY A 77 ALA A 83 1 O LEU A 79 N VAL A 9 SHEET 5 AA1 6 MET A 111 ASN A 116 1 O ASN A 116 N PHE A 82 SHEET 6 AA1 6 PHE A 141 GLU A 143 1 O ILE A 142 N LEU A 113 SHEET 1 AA2 6 GLU B 37 ILE B 46 0 SHEET 2 AA2 6 GLU B 49 THR B 58 -1 O ASP B 57 N ASP B 38 SHEET 3 AA2 6 THR B 2 VAL B 9 1 N TYR B 4 O ASP B 54 SHEET 4 AA2 6 GLY B 77 ALA B 83 1 O LEU B 79 N VAL B 9 SHEET 5 AA2 6 MET B 111 ASN B 116 1 O ASN B 116 N PHE B 82 SHEET 6 AA2 6 PHE B 141 GLU B 143 1 O ILE B 142 N LEU B 113 SHEET 1 AA3 8 ARG C 55 ILE C 57 0 SHEET 2 AA3 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55 SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62 SHEET 4 AA3 8 ILE C 97 MET C 100 -1 N SER C 99 O PHE C 113 SHEET 5 AA3 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98 SHEET 6 AA3 8 GLU C 15 LEU C 24 -1 N SER C 21 O LYS C 133 SHEET 7 AA3 8 THR C 5 VAL C 12 -1 N ILE C 10 O GLY C 18 SHEET 8 AA3 8 ILE C 156 LEU C 164 -1 O ASP C 160 N ASP C 9 SHEET 1 AA4 8 PHE D 53 ILE D 57 0 SHEET 2 AA4 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55 SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62 SHEET 4 AA4 8 ILE D 97 MET D 100 -1 N ILE D 97 O CYS D 115 SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98 SHEET 6 AA4 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133 SHEET 7 AA4 8 THR D 5 VAL D 12 -1 N ILE D 10 O LEU D 17 SHEET 8 AA4 8 ILE D 156 GLU D 165 -1 O ASP D 160 N ASP D 9 LINK OG SER A 17 MG MG A 202 1555 1555 2.05 LINK OG1 THR A 35 MG MG A 202 1555 1555 2.04 LINK O1G GNP A 201 MG MG A 202 1555 1555 2.01 LINK O2B GNP A 201 MG MG A 202 1555 1555 2.04 LINK MG MG A 202 O HOH A 324 1555 1555 2.05 LINK MG MG A 202 O HOH A 336 1555 1555 2.09 LINK OG SER B 17 MG MG B 202 1555 1555 2.09 LINK OG1 THR B 35 MG MG B 202 1555 1555 2.07 LINK O1G GNP B 201 MG MG B 202 1555 1555 2.00 LINK O2B GNP B 201 MG MG B 202 1555 1555 2.05 LINK MG MG B 202 O HOH B 327 1555 1555 2.05 LINK MG MG B 202 O HOH B 359 1555 1555 2.08 CRYST1 65.470 83.570 126.210 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015274 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011966 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007923 0.00000